QUANTRX BIOMEDICAL CORPORATION – Trademark Portfolio
Entity Type: 03
QUANTRX BIOMEDICAL CORPORATION holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PADKIT. The owner is based in Portland, OR.
5920 NE 112th Avenue
Corporate Research Center
Portland, OR 97220
Showing of trademarks Trademarks
Trademark Classifications
QUANTRX BIOMEDICAL CORPORATION's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does QUANTRX BIOMEDICAL CORPORATION have?
QUANTRX BIOMEDICAL CORPORATION has 16 U.S. trademarks filed with the USPTO. Of these, 1 registered, 11 abandoned, 4 cancelled.
What trademark classes does QUANTRX BIOMEDICAL CORPORATION file in?
QUANTRX BIOMEDICAL CORPORATION files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are QUANTRX BIOMEDICAL CORPORATION's most well-known trademarks?
QUANTRX BIOMEDICAL CORPORATION's registered trademark portfolio includes well-known marks such as PADKIT. These are among 1 currently registered trademark in the portfolio.
What is QUANTRX BIOMEDICAL CORPORATION's trademark registration success rate?
QUANTRX BIOMEDICAL CORPORATION has a 6% trademark registration rate, with 1 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.